Reference
Wali GN, et al. Persistent granulomatous cutaneous drug eruption to a BRAF inhibitor. Journal of the American Academy of Dermatology 76 (Suppl. 1): AB195 abstr. 5135, No. 6, Jun 2017. Available from: URL: http://doi.org/10.1016/j.jaad.2017.04.761 [abstract] - United Kingdom
Rights and permissions
About this article
Cite this article
Dabrafenib. Reactions Weekly 1748, 157 (2019). https://doi.org/10.1007/s40278-019-60073-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-60073-9